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ABSTRACT Alternatives to cell culture systems for pro-
duction of recombinant proteins could make very safe vac-
cines at a lower cost. We have used genetically engineered
plants for expression of candidate vaccine antigens with the
goal of using the edible plant organs for economical delivery
of oral vaccines. Transgenic tobacco and potato plants were
created that express the capsid protein of Norwalk virus, a
calicivirus that causes epidemic acute gastroenteritis in hu-
mans. The capsid protein could be extracted from tobacco
leaves in the form of 38-nm Norwalk virus-like particles.
Recombinant Norwalk virus-like particle (rNV) was previ-
ously recovered when the same gene was expressed in recom-
binant baculovirus-infected insect cells. The capsid protein
expressed in tobacco leaves and potato tubers cosedimented in
sucrose gradients with insect cell-derived rNV and appeared
identical to insect cell-derived rNV on immunoblots of
SDS/polyacrylamide gels. The plant-expressed rNV was
orally immunogenic in mice. Extracts of tobacco leaf express-
ing rNV were given to CD1 mice by gavage, and the treated
mice developed both serum IgG and secretory IgA specific for
rNV. Furthermore, when potato tubers expressing rNV were
fed directly to mice, they developed serum IgG specific for
rNV. These results indicate the potential usefulness of plants
for production and delivery of edible vaccines. This is an
appropriate technology for developing countries where vac-
cines are urgently needed.
Norwalk virus is a member of the Caliciviridae family and
causes epidemic acute gastroenteritis in humans (1, 2). Previ-
ous studies estimated that -42% of outbreaks of acute epi-
demic gastroenteritis in the United States are caused by
Norwalk and Norwalk-like viruses (3). Recent advances in
cloning the Norwalk virus genome (1) and expression of the
capsid protein in recombinant baculovirus-infected insect cells
(4) have facilitated the study of the virus and the development
of a candidate vaccine (5).
Expression of the Norwalk virus capsid protein (NVCP) in
insect cells yields a protein with an apparent Mr of 58,000 that
self-assembles into insect cell-derived Norwalk virus-like par-
ticles (i-rNVs) lacking viral RNA, which are reactive with sera
from Norwalk virus-infected humans (4). Electron cryomi-
croscopy of i-rNV shows that the 38-nm empty capsid is
composed of 90 dimers of NVCP that form arch-like capsom-
eres (6). The particles are morphologically and antigenically
similar to authentic virus particles, stable on storage at 4°C,
stable after lyophilization, and resistant to pH 3.0 treatment (4,
7). These qualities make i-rNV attractive for use as a potential
vaccine against Norwalk virus. Recent studies showed that oral
immunization of mice with as little as 50 ,ug of i-rNV per dose
resulted in the production of serum and mucosal antibodies
against NVCP (5). This result is striking in view of the fact that
i-rNV is a nonreplicating vaccine and no cholera toxin (CT)
adjuvant is needed to achieve immunization.
We have experimented with the use of plants as an eco-
nomical alternative for expression and delivery of recombinant
vaccines (8-10). Hepatitis B surface antigen (HBsAg) ex-
pressed in tobacco leaves forms subviral particles (8) that are
similar to the recombinant yeast-derived antigen, which is
licensed for parenteral immunization (11). The plant-derived
HBsAg retains both B- and T-cell epitopes when studied in a
mouse model (10). Furthermore, the Escherichia coli heat-
labile enterotoxin B-subunit expressed in potato tubers and fed
to mice without preparation (other than slicing) stimulates
serum and gut mucosal antibodies against E. coli labile en-
terotoxin B-subunit (9). These studies provide proof that
recombinant antigens can be produced in transgenic plants,
and, at least in some cases, these antigens are orally immuno-
genic.
We report here the expression of recombinant NVCP in
transgenic tobacco leaves and potato tubers. The NVCP from
tobacco leaves self-assembles into tobacco-derived virus-like
particles (t-rNVs) that are morphologically and physically
similar to i-rNVs. Further, we show that either partially
purified t-rNV given orally or potato tubers expressing NVCP
fed directly to mice stimulate the production of antibodies
against NVCP. We conclude that a plant-derived edible vac-
cine for Norwalk virus is feasible. Together with our previous
studies, these findings bolster the concept of using transgenic
plants for a novel, safe vaccine production and delivery system
for developing countries.
MATERIALS AND METHODS
Construction of Plant Expression Vectors. A 2.4-kbp DNA
fragment containing the gene encoding NVCP was obtained by
partialEcoRI digestion ofpUCNV4145 (1) and subcloned into
pBluescript-KS (Stratagene) at the EcoRI site. One clone
(pKSNV2.4) was digested with SmaI and SstI; the resulting
1.9-kbp fragment was ligated with pBI121 (Clontech; ref. 12)
at SmaI/SstI. This gave pNV101, a binary vector for expression
of NVCP in plants using the cauliflower mosaic virus 35S
promoter to drive transcription and the nopaline synthase
terminator (Fig. 1).
pNV102 was constructed as follows. pUCNV4145 was di-
gested with HindIII followed by blunt-ending with mung bean
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FIG. 1. Plasmids used for expression of rNV in plants. Shown are
the transferred DNA regions of binary vectors used forAgrobacterium-
mediated transformation of tobacco and potato plants. RB and LB
indicate the right and left transferred DNA borders that delineate the
region transferred into plant cells and inserted into the nuclear DNA.
Each plasmid contains a nptII expression cassette for selection of plant
transformants using kanamycin. pNV101 and pNV102 use the cauli-
flower mosaic virus 35S promoter to drive transcription, while pNV140
uses the patatin promoter for tuber-specific expression. pNV102 and
pNV140 also contain the TEV 5'-UTR for stimulation of translation
initiation. pNV140 contains a NVCP coding region modified to
contain a NcoI site surrounding the translation initiation codon.
nuclease, and then it was digested with XbaI to give a 1.3-kbp
fragment containing the 3'-terminal 1125 bp of NVCP coding
region and 178 bp of noncoding region. This fragment was
ligated with pBI201 (Clontech) that had been digested with
SstI, blunt-ended with mung bean nuclease, and then digested
with XbaI to give pNV3. A 900-bp fragment containing a
cauliflower mosaic virus 35S promoter with duplicated en-
hancer region fused to the tobacco etch virus (TEV) 5'-
untranslated region (UTR) was obtained by digestion of
pRTL2-GUS (13) with NcoI, followed by blunt-ending with
mung bean nuclease and HindIII. This fragment was ligated
with pNV3 digested with PstI, followed by blunt-ending with
mung bean nuclease and HindIlI to give pNV4. The 471-bp
5'-terminal NVCP coding region was obtained by digestion of
pUCNV4145 with EcoRI followed by mung bean nuclease and
thenXbaI, and then it was ligated with pNV4 digested with Sall
followed by mung bean nuclease and XbaI to give pNV202.
Finally, the HindIII/EcoRI fragment from pNV202 was li-
gated with pBI121 at HindIII/EcoRI to give pNV102 (Fig. 1).
pNV140, a vector using the patatin promoter (14) to drive
expression of NVCP, was constructed as follows. A NcoI site
was created at the third in-frame ATG codon of NVCP (15)
with PCR using the mutagenic primer 5'-AAAACCATG-
GCGTCTAAGGAC-3' along with the downstream primer
5'-CTGCTACAGGATCCA-3'. The resulting fragment of 106
bp was digested with NcoI and BamHI and ligated with the
1765-bp BamHI/SstI fragment from pUCNV4145, and the
expression vector pIBT210 (9) that was digested with NcoI and
SstI to give pNV210. The NVCP coding region with the
modified 5' end fused to the TEV 5'-UTR was obtained by
digestion of pNV210 with XhoI, partial filling with Klenow
fragment and dCTP/dTTP, and digestion with SstI. This 2-kbp
fragment was ligated with pPS20A-G (14) that was digested
withBamHI, partially filled with Klenow fragment and dGTP/
dATP, and digested with SstI to give pNV140 (Fig. 1).
Plant Transformation. Plasmids NV101, NV102, and
NV140 were mobilized into Agrobacterium tumefaciens
LBA4404 by the freeze-thaw method (16), using plasmids
cloned in E. coli DHSa. The structures of plasmids in trans-
formed LBA4404 lines were verified by restriction digestion.
Tobacco (Nicotiana tabacum "Samsun") (8) and potato [So-
lanum tuberosum "Frito-Lay (FL) 1607"] (9, 14) were trans-
formed by modified leaf-disc cocultivation methods using the
Agrobacterium strains described above. Kanamycin-resistant
transformants were screened for NVCP expression by RNA
hybridization and ELISA (below). Tissue culture microtubers
and soil-grown tubers from transgenic potato plants were
developed as described (9).
NVCP ELISA. NVCP in plant extracts was quantified by
ELISA as described (4, 17). Rabbit anti-(i-rNV) serum diluted
1:10,000 in 0.01 M phosphate-buffered saline (PBS; 50,lI per
well) was bound to 96-well polyvinylchloride microtiter plates
for 4 h at 23°C, and the plates were blocked with 5% nonfat dry
milk in PBS (DM/PBS) for 1 hat 37°C. After washing the wells
three times with PBS with 0.05% Tween 20, samples (50,u per
well) diluted in PBS were added and incubated 16 hat 4°C. The
wells were washed and incubated in succession with guinea pig
anti-(i-rNV) serum and goat anti-guinea pig IgG-horseradish
peroxidase conjugate, each diluted 1:5000 in 2% DM/PBS, for
2 h at 37°C. The plate was developed with Slow TMB substrate
(Pierce) for 15-20 min at 23°C, the reaction was ended by
addition of an equal volume of 0.5 M H2SO4, and the absor-
bance was read at 450 nm. For a standard curve, i-rNV was
diluted with PBS to concentrations between 1.4 and 45 ng/ml
and processed as above.
RNA Extraction and Hybridization. Total RNA was ex-
tracted from leaves of tobacco, fractionated on formaldehyde
gels, and blotted to nylon membranes as described (8). The
membranes were hybridized with 32P-labeled random-primed
DNA made using the 1.3-kbp BamHI/EcoRI fragment from
pUCNV4145 as template as described (8), and signals were
quantified with a Phosphorlmager (Molecular Dynamics).
Extraction and Purification of Recombinant Norwalk Vi-
rus-Like Particle (rNV) from Plant Tissues. Microtubers were
homogenized in extraction buffer (PBS, pH 7.2/50 mM so-
dium ascorbate/2 mM EDTA/1 mM phenylmethylsulfonyl
fluoride/0.2% Triton X-100) by crushing with a "pellet pestle"
(Fisher Scientific) in 1.5-ml microcentrifuge tubes. Soil-grown
tubers were weighed, skinned, and sliced before homogeniza-
tion in extraction buffer with a Ten-Broek (Fisher) apparatus
(clearance 0.15 mm). Homogenates were microcentrifuged 5
min at 14,000 x g at 4°C, and supernatants were tested for
NVCP by ELISA and for total protein by the Coomassie blue
dye binding assay (Bio-Rad), with BSA as a standard.
Tobacco leaves (10-20 cm long) were harvested, frozen in
liquid N2, and ground to a fine powder in a stainless steel
blender precooled with liquid N2. Approximately 250 g of leaf
powder was suspended in 500 ml of extraction buffer and
stirred at 4°C for 4-16 h. The slurry was centrifuged at 3,000
x g for 20 min at 4°C in a Sorvall GS-3 rotor, and the
supernatant was centrifuged again at 15,000 X g for 40 min in
a Sorvall F16/250 rotor. The rNV particles were pelleted from
the resulting supernatant by centrifugation at 100,000 x g for
2 h in a Beckman SW 28 rotor. The pellet was suspended in
PBS, and cleared by centrifugation at 10,000 x g for 5 min in
a Sorvall F18/50 rotor. Fbur milliliters of the cleared suspen-
sion was loaded on a 32-ml discontinuous sucrose gradient
made by layering 7 ml each of 50% and 40% sucrose in PBS
and 6 ml each of 30%, 20%, and 10% sucrose in PBS. The
gradients were centrifuged at 53,000 x g for 14 h at 4°C in a
Beckman SW 28 rotor, and fractions were analyzed by ELISA
or SDS/PAGE and Western blot. Fractions that cosedimented
with i-rNV particles were combined and concentrated, and
buffer (PBS) was exchanged by centrifugal ultrafiltration with
a Centriprep-30 (Amicon).
Analytical Anion Exchange Chromatography and Electron
Microscopy of rNV. Eight milligrams of total protein prepared
by sucrose gradient as described above for t-rNV or as
described for i-rNV (4) was loaded on a Pharmacia Mono-Q
HR 5/5 column in 5 ml of buffer A (20mM Tris HCl, pH 7.5).
The column was eluted with a continuous gradient of 0-100%
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buffer B (500mM NaCl in buffer A) at a flow rate of 1 ml/min.
Fractions were collected and tested for NVCP by ELISA. Peak
fractions were pelleted by centrifugation at 100,000 x g for 2
h, resuspended in 1% ammonium molybdate (pH 6.0), and
examined by transmission electron microscopy on a Phillips
CM10 microscope (Phillips Electronic Instruments, Mahwah,
NJ).
SDS/PAGE and Western Blotting. Tobacco leaf extracts
were fractionated on 10% or 12% polyacrylamide gels using
the buffer system of Laemmli (18), and proteins were trans-
ferred to nitrocellulose in Towbin buffer (19) using a semidry
blotter (Bio-Rad) at 20 V for 20 min. The membranes were
blocked with 5% DM/PBS for 1 h at 23°C and probed in
succession with guinea pig anti-(i-rNV) (4) diluted 1:2000 in
2% DM/PBS and goat anti-guinea pig IgG-horseradish per-
oxidase conjugate (Sigma) diluted 1:3000 in 2% DM/PBS.
Bound antibody was detected with ECL reagent (Amersham).
Immunogenicity Testing in Mice. Tobacco leaf extracts
prepared by sucrose gradient sedimentation as described
above were administered to CD1 mice by gastric intubation
(gavage). Various doses (10-80 jig of t-rNV) or an equivalent
dose of an extract of nontransformed control tobacco leaves
were given with or without CT on days 1, 2, 11, and 28. For
tuber feeding, mice were fasted overnight before consuming
-4 g of transgenic tuber (40-80 ,ug of rNV by ELISA) on days
1, 2, 11, and 28. Tubers were prepared for feeding by peeling
and slicing, and individual mice were monitored to verify
consumption of the entire dose. In some cases, 10 ,ug per dose
of CT was added to the sliced tubers. Tail blood was obtained
before immunization and on days as shown in Fig. 5 and tested
for anti-NVCP immunoglobulins by ELISA as described (4,
17). Fecal samples were collected on days 6, 19, and 37 and
A pNV101 pNV102
1 2 3 4 5 6 7 8
tested for total IgA and anti-NVCP IgA by a modification (5)
of a method described (20).
RESULTS
Expression Vectors and Selection of Transformed Plants.
The plasmids for expression of NVCP in plants (Fig. 1) allow
selection of transformants on media containing kanamycin.
The right and left borders flank the expression cassettes and
delineate the transferred DNA, which is stably integrated into
nuclear chromosomal DNA at random sites and mediated by
Agrobacterium infection (21). pNV101 and pNV102 use the
cauliflower mosaic virus 35S promoter to drive nominally
constitutive transcription. pNV102 differs in the insertion of
the TEV 5'-UTR, which stimulates translation by a cap-
independent mechanism (22), a duplicated enhancer region in
the 35S promoter (13), and the removal of part of the 3'-UTR
derived from the NVCP clone pUCNV4145 (1). pNV140 uses
the promoter from the major potato tuber storage protein,
patatin (14), to drive transcription and contains the TEV
translational enhancer fused to a translation initiation site
modified to remove the two ATG codons immediately pre-
ceding the NVCP initiation codon. The patatin promoter is
active preferentially in tubers (14).
NVCP Expression and the Effect of TEV 5'-UTR. Because
the site of insertion of the transferred DNA into the cellular
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FIG. 2. Effect of TEV 5'-UTR on expression of NVCP in tobacco
leaves. (A) Four independent transformants with pNV101 (lacking
TEV 5'-UTR) and pNV102 (containing TEV 5'-UTR) were analyzed
for NVCP-specific mRNA by RNA blot hybridization. Five micro-
grams of total leafRNA was fractionated, blotted, and hybridized with
NVCP-specific probe. Lanes 1-4, pNV101 transformants; and lanes
5-8, pNV102 transformants. (B) The same leaf tissue analyzed in A
was assayed for NVCP and total protein. The NVCP (in ng/mg of total
protein) was plotted versus the relative RNA abundance from blotA,
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FIG. 3. (A) Sucrose gradient sedimentation of i-rNV and t-rNV.
Approximately 3 jig of t-rNV prepared by sucrose gradient sedimen-
tation or 4.5 ,ug of i-rNV expressed in recombinant baculovirus-
infected insect cells (4) in a sample volume of 0.1 ml was sedimented
in discontinuous sucrose gradients (0.95 ml each of 10%, 20%, 30%,
40%, and 50% sucrose in PBS) at 50,000 rpm at 4°C for 3.5 h in a
Beckman SW 55Ti rotor. Fractions were tested for NVCP by ELISA
(A450). (B) SDS/PAGE and Western blot of i-rNV and sucrose
gradient-purified t-rNV. The three different preparations of t-rNV
were obtained by sucrose gradient, and they are the same preparations
used for mouse feeding studies. Lane 1, 200 ng of i-rNV; lane 2, 600
ng of t-rNV preparation 1; lane 3, 300 ng of t-rNV preparation 1; lane
4, 400 ng of t-rNV preparation 2; lane 5, 200 ng of t-rNV preparation
2; and lane 6, 1050 ng of t-rNV preparation 3.
so
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FIG. 4. i-rNV and t-rNV particles visualized by negative staining
and electron microscopy. The peak fractions from ion exchange
chromatography of t-rNV (A) or i-rNV (B) were pooled and pelleted
at 100,000 x g, and processed for negative staining and electron
microscopy. (Bar = 100 nm.)
transcripts in independent transformants is expected. This
finding is illustrated in Fig. 2A4, which is a blot of total leafRNA
probed with NVCP coding sequences. Varying levels of
NVCP-specific RNA among the independent transformants
were apparent. In those showing higher levels of NVCP
mRNA, two smaller transcripts appeared, perhaps as a result
of alternative 3' end processing or splicing.
To assess the effect of the TEV 5'-UTR on translational
efficiency of NVCP mRNA, we measured mRNA and antigen
levels on the same leaf samples. NVCP antigen levels plotted
versus RNA abundance in Fig. 2B showed a substantial
difference between the pNV101 and pNV102 constructs. The
slopes of the regression lines for these data indicate that the
mRNA derived from the pNV102 cassette, which carries the
TEV translational enhancer, allows 3-fold higher accumula-
tion of NVCP antigen, presumably due to more efficient
initiation of translation (22). We therefore used the TEV
5'-UTR in pNV140 (Fig. 1).
The maximum level of NVCP accumulation in the leaves of
tobacco transformants was 0.23% of the total soluble protein.
Similar accumulation levels were obtained with tubers of potato
plants transformed with pNV140, using the patatin promoter
fused to the TEV 5'-UTR. For mouse feeding studies, we used
tubers that were in the size range of 4-20 g and averaged -10-20
,g of rNV per g of tuber weight.
NVCP from Tobacco and Potato Sediments as rNV Parti-
cles. To test whether the NVCP produced in tobacco leaves
forms virus-like particles, we sedimented partially purified
extracts and i-rNV on sucrose gradients and monitored the
antigen in gradient fractions. Fig. 3A shows that NVCP in
tobacco leaf extracts (t-rNV) cosedimented with i-rNV. A
peak near the top of the gradient indicates that a small
proportion of NVCP is present as soluble protein or smaller
aggregates. Sucrose gradients on crude 10,000 x g superna-
tants from tobacco leaves and potato tubers expressing NVCP
showed that "50-60% of the ELISA reactive material cosedi-
ments with i-rNV (data not shown). Further characterization
of t-rNV by isopycnic CsCl gradient banding showed that the
ELISA-positive material had a buoyant density of 1.31 g/ml
(data not shown), which is consistent with that observed for
i-rNV (4).
t-rNV Comigrates with i-rNV on SDS/PAGE. The t-rNV
prepared by sucrose gradient constituted 20-30% of the total
protein in the fraction, as judged by Coomassie blue staining
of SDS/polyacrylamide gels (data not shown). The Western
blot in Fig. 3B shows that t-rNV comigrated with i-rNV at 58
kDa. A minor band was observed in both i-rNV and t-rNV
preparations at -55 kDa. Although not observed in this blot,
other t-rNV blots sometimes showed a smaller reactive frag-
ment at -34 kDa, which might represent one of several
proteolytic cleavage products of the 58-kDa protein (4, 23).
NVCP from Tobacco Forms Virus-Like Particles. Further
purification of i-rNV and t-rNV by anion exchange chroma-
tography showed parallel elution of ELISA-positive material
on the NaCl gradient (data not shown). We prepared i-rNV
and t-rNV by pelleting the peak fractions from anion exchange
chromatography and examined the resulting protein by nega-
tive staining and electron microscopy (Fig. 4). This analysis
Table 1. Immune response of CD1 mice fed t-rNV and potato-expressed rNV
Serum antibody* Fecal IgAt
No.
rNV* No. positive ELISA positive/
Group ,ug Adjuvantt Expression/delivery total titers, range total
1 10 10 ,ug CT tobacco/oral 4/4 100-800 1/4
2 50 10 ,ug CT tobacco/oral 9/10 50-3200 5/9
3 50 None tobacco/oral 8/9 50-800 5/8
4 80 10 ,ug CT tobacco/oral 3/3 1600-25,600 ND
5 0 None control tobacco/oral 0/5 <25 ND
6 40-80§ 10 ,ug CT potato/eaten 7/10 50-200 0/10
7 40-80§ None potato/eaten 4/10 50-200 1/10
8 0 None control potato/eaten 0/6 <25 ND
ND, not determined.
*rNV particles were expressed in tobacco leaves or in potato tubers. The concentration of the expressed
rNV particles in the partially purified tobacco extracts and in tuber tissue was determined by ELISA as
described. Transformed and untransformed (control) tobacco extracts were administered to CD1 mice
by gavage; transformed and untransformed potato tubers were peeled, cut into small pieces, and
administered by feeding.
tTen micrograms of CT was mixed with tobacco extracts or added directly to tuber slices before
administration.
trNV-specific serum antibody and fecal IgA titers at day 40 (see Fig. 5) were determined by ELISA as
described. A reaction was considered to be positive if the titer was 4-fold greater than preimmunization
titer.
§The expression levels of rNV varied between 10 and 20 ,ug per g of tuber tissue; mice were fed 4 g tuber
per dose.
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revealed empty virus-like particles virtually indistinguishable
from i-rNV (4) in both size and appearance.
Oral Immunogenicity of Tobacco and Potato rNV in Mice.
We used partially purified t-rNV from sucrose gradients and
potato rNV in sliced tubers to test the oral immunogenicity of
plant-derived rNV in mice. When CT was given with 50 ,ug per
dose of t-rNV, 9 of 10 mice responded with measurable serum
anti-NVCP; when the same dose of t-rNV was given without
CT, eight of nine mice also responded with serum anti-NVCP,
although the titers were lower than those given CT (Table 1).
CT stimulated higher geometric mean titers during earlier
phases of immunization, but at the final time point (40 days
after the first immunization), the geometric mean titers for
mice with and without CT were very similar (Fig. SA). As little
as 10 ,ug t-rNV per dose (with CT) stimulated serum and fecal
antibodies, and much higher serum titers were seen with 80 jig
t-rNV (Table 1). These data are consistent with those showing
successful oral immunization in mice and humans using i-rNV
(5) and indicate that plant-derived rNV is an orally active
immunogen.
Intestinal rNV-specific and total IgA levels in the mice of
Fig. SA were assayed by ELISA. Of the mice that had a positive





























FIG. 5. Kinetics of serum antibody responses in mice immunized
with rNV expressed in tobacco (A) or potato (B). (A) Ten CD1 mice
each were gavaged with 50 jig of t-rNV with or without 10 jig of CT
on days 1, 2, 11, and 28. (B) Ten CD1 mice each were fed 4 g of
transgenic potato tuber expressing rNV (10-20 ,ug/g tuber) with or
without 10 ,g of CT on days 1, 2, 11, and 28. Tail blood was sampled
on days shown, and serum was assayed by ELISA for anti-NVCP. The
ELISA geometric mean titers are shown on the ordinate, and the time
(in days) is shown on the abscissa. Fractions above data bars indicate
number of responder mice per total number of mice tested.
nine (with CT) and five of eight (without CT) also had
measurable NVCP-specific intestinal IgA. Specific IgA levels
ranged from 0.33 to 4.12 ng/,ug (with CT) and from 0.08 to 4.21
ng/,g (without CT).
Mice were fed potato tubers expressing NVCP at 40-80 ,ug
per dose with or without CT at 10 ,ug/dose. Only about half of
the NVCP in potato tubers was in particle form. When the
material was fed with CT, 7 of 10 mice responded with serum
anti-NVCP antibody, and 4 of 10 responded when CT was
omitted (Fig. SB and Table 1). The serum titers were lower
than those of mice gavaged with gradient-purified t-rNV at a
similar dose (Fig. 5A). Of the 11 serum responders, only 1
mouse had measurable intestinal IgA (Table 1).
DISCUSSION
Our previous work with HBsAg (8, 10) and E. coli labile
enterotoxin B-subunit (9) showed that plants can produce
recombinant viral and bacterial antigens that retain immuno-
genic epitopes and assemble into the proper quaternary con-
figurations required for maximal functionality. The present
work shows similar data for a different viral antigen, NVCP.
Expression ofrNV in tobacco leaves resulted in the production
of virus-like particles that were similar to i-rNV, supporting the
idea that plant cells can manufacture functional capsids of
animal viruses.
We obtained rNV expression levels of up to 0.23% of total
soluble protein in tobacco leaves, and up to 0.37% in potato
tubers (34 ,ug per g of tuber weight). These data represent a
substantial increase over that obtained for HBsAg in tobacco
leaves, which gave a maximum of 0.01% total soluble protein
(8). The reasons for the great difference are unclear but may
be related to the subcellular localization of each peptide.
HBsAg is a glycoprotein targeted to the endoplasmic reticulum
in liver cells by an internal, uncleaved signal sequence (24),
whereas Norwalk virions likely accumulate in the cytoplasm of
infected cells. Thus it is possible that rNV accumulates more
efficiently in plant cells because it is cytoplasmic and requires
no subcellular targeting. Studies on plant expression of HBsAg
and NVCP with plant-derived N-terminal signal sequence
fusions may provide information on the importance of efficient
ER-targeting for accumulation of foreign proteins.
Plant-derived rNV delivered orally to mice stimulated the
production of humoral and mucosal antibody responses (Fig.
5 and Table 1). This confirms the similar observations on oral
delivery of i-rNV (5), but further shows that consumption of
recombinant plant material (potato tuber) by normal feeding
allows immunogenic responses. The immune response to rNV
delivered as food in transgenic potato tubers was lower than
that obtained by gavage with a similar dose (measured by
ELISA) of partially purified t-rNV, perhaps because the tuber
material was consumed more slowly and was less pure. Further,
while the t-rNV purified by sucrose gradient sedimentation
contained mostly virus-like particles, only about half of the
ELISA-reactive material extracted from tubers was in the
particle form, as judged by analytical sucrose gradients. The
particle form should be more stable in the stomach (4) and
more readily taken up byM cells in the gut for presentation to
lymphocytes in the Peyer's Patches (25); therefore, the func-
tionally active (particulate) rNV in potato tubers may be only
half the concentration that we measure by ELISA, or about
20-40 j,g per dose.
CONCLUSIONS
Taken together, the results presented here add further evi-
dence to support the concept (8, 9) of edible vaccines: oral
consumption of recombinant plant tissues expressing NVCP
evokes specific immunoglobulin production. Although im-
mune responses to dietary antigens, in the form of either active
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antibody production or oral tolerance, have been known for
some time (25), the intentional stimulation of immunity via
ingestion of recombinant plant material has only recently been
shown (9). While it may not be surprising to see stimulation of
immunity to fed antigens, it was by no means a foregone
conclusion and required these seminal experiments to show a
proof of the concept. We have not shown neutralizing activity
in this report because no assay is yet available to assess
Norwalk virus neutralization. However, we anticipate conduct-
ing human feeding trials for the direct assessment of protection
afforded by ingestion of recombinant potato tubers against
Norwalk virus infection.
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